Last Updated: 22/05/2026
Framework for Optimising Control at the Local Level: Coordinated strategies for Neglected Tropical Diseases and Malaria (FOCAL-NTD)
Objectives
The aim of this project is to develop a framework that enables disease control efforts to be targeted more effectively. In addition to considering individual diseases, the framework will encourage coordination between control programmes in areas where multiple diseases are co-endemic, thus accelerating these programmes simultaneously towards their control/elimination goals.
Liverpool School of Tropical Medicine (LSTM), United Kingdom
Disease control programmes require knowledge of the geographical distribution of the target disease in order to establish where control interventions are most needed. In instances where the disease risk is approximately constant across a geographical area (i.e. spatially homogeneous), programmes are able to evenly distribute interventions amongst the population. However, disease risk can often be very variable (i.e. spatially heterogeneous), particularly in the case of parasitic diseases in which the relationship between the parasite and the human host is dependent on the surrounding environment. In these instances a ‘blanket’ intervention approach isn’t sufficient to eliminate a disease from an area, as resources are wasted in areas where there is no disease risk, and are not adequately focused to completely remove disease ‘hotspots’.
This project will focus on three neglected tropical diseases (NTDs) and coinfections with malaria in order to demonstrate the flexibility of the framework being developed. These NTDs are Human African Trypanosomiasis (HAT, transmitted by tsetse flies) schistosomiasis (transmitted in freshwater by an intermediate host snail) and lymphatic filariasis (LF, transmitted by mosquitoes). Local level risk maps for each of these diseases will be produced using data provided by project collaborators from endemic countries, including Malawi and Uganda. These maps will combine disease/vector/intermediate host information with information on the risk factors of the diseases in question. Geographically referenced risk factors could include those that influence the presence and/or density of the disease’s vector/intermediate host, or influence how likely a person is to come into contact with the vector/intermediate host. Using the example of schistosomiasis, this may include factors such as the distance of the village to the nearest freshwater source, factors influencing the intermediate host/parasite ability to survive and breed (e.g. altitude, temperature, vegetation) and information on control activities have been implemented in the area.
Traditional methods of collecting local level disease risk data use survey teams to collect information, with surveys often being expensive, time-consuming and logistically difficult to undertake in rural areas of developing countries. In addition to developing risk maps based on previously collected information, alternative methods for obtaining local level disease-related data will be explored. Two approaches will be considered. Firstly, more efficient spatial sampling methods for determining which sites should be surveyed will be developed. These methods will be ‘flexible’ in the sense that the selection of sites to sample will be done iteratively, and will be selected strategically in order to reduce the uncertainty in the estimated geographical distribution of disease risk in the study area. The second approach focuses on using community members to collect disease-related information, as opposed to a dedicated survey team. Community members are becoming increasingly involved in disease control activities in developing countries, and this has been shown to improve intervention coverage and acceptability. This project will explore ways in which community members can more directly contribute to disease control activities through the development of mobile phone-based surveillance and reporting tools. Community members in Malawi and Uganda will be trained to report information such as preventive therapy coverage (for schistosomiasis and LF) and vector control (malaria and HAT) respectively.
Jul 2015 — Jul 2018
$602,740


